[PTGX] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
14-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- 0.20%
YoY- -105.39%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -14,979 -14,101 -11,248 -7,084 -7,098 -11,747 -5,493 95.30%
Tax 0 0 -75 0 -27 4,707 492 -
NP -14,979 -14,101 -11,248 -7,084 -7,098 -11,747 -5,493 95.30%
Tax Rate - - - - - - - -
Total Cost 14,979 14,101 11,248 7,084 7,098 11,747 5,493 95.30%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS -0.89 -0.84 -0.67 -0.84 -0.43 -2.00 -0.93 -2.89%
EPS Diluted -0.89 -0.84 -0.67 -0.84 -0.43 -2.00 -0.93 -2.89%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.